Pathophysiology and Therapeutics, Hokkaido University Faculty of Pharmaceutical Sciences, kita-12, nishi-6, kita-ku Sapporo, 060-8638, Japan.
Pathophysiology and Therapeutics, Hokkaido University Faculty of Pharmaceutical Sciences, kita-12, nishi-6, kita-ku Sapporo, 060-8638, Japan.
Toxicol Lett. 2021 Mar 15;339:51-59. doi: 10.1016/j.toxlet.2020.12.015. Epub 2020 Dec 25.
Overdose use of acetaminophen (APAP) often occurs a severe liver injury, and its liver injury is lethal in some cases. Macrophage migration inhibitory factor (MIF) is expressed in a variety of cells and has multifunctional roles. However, the role of MIF in APAP-induced liver injury has not been fully investigated. In this study, we investigated whether treatment with (S,R)-3-(4-hydroxyphenil)-4,5-dihydro-5-isoxazole acetic acid methyl ester (ISO-1), a MIF inhibitor, protected mice from acute APAP-induced liver injury. Acute liver injury was induced by injection of APAP (300 mg/kg body weight). Mice were treated with a single injection of ISO-1(15 mg/kg body weight) 1 h (h) before APAP administration. Histological, biochemical and molecular analyses were performed in liver of mice 12 h after APAP administration. ISO-1 remarkably improved the histological findings of APAP-induced liver injury in mice. The increases in serum levels of alanine aminotransferase (ALT), and macrophage inflammatory protein-2 (MIP-2) by APAP were inhibited by ISO-1. In addition, ISO-1 reduced the increased number of the myeloperoxidase-staining cells and that of TUNEL-positive staining cells in the liver of mice with APAP-induced liver injury. Up-regulation of hepatic receptor interacting protein kinase (RIPK)3 and heat shock protein70 by APAP was suppressed in the liver of mice given ISO-1. These results provide the additional evidence that inhibition of MIF activity may be clinically effective for treatment of acute APAP-induced liver injury.
过量使用对乙酰氨基酚(APAP)常导致严重肝损伤,在某些情况下其肝损伤是致命的。巨噬细胞移动抑制因子(MIF)在多种细胞中表达,具有多种功能。然而,MIF 在 APAP 诱导的肝损伤中的作用尚未得到充分研究。在本研究中,我们研究了 MIF 抑制剂(S,R)-3-(4-羟基苯基)-4,5-二氢-5-异恶唑乙酸甲酯(ISO-1)治疗是否能保护小鼠免受急性 APAP 诱导的肝损伤。通过注射 APAP(300mg/kg 体重)诱导急性肝损伤。APAP 给药前 1h 给予 ISO-1(15mg/kg 体重)单次注射进行治疗。APAP 给药 12h 后对小鼠肝脏进行组织学、生化和分子分析。ISO-1 显著改善了 APAP 诱导的肝损伤小鼠的组织学发现。ISO-1 抑制了 APAP 引起的血清丙氨酸氨基转移酶(ALT)和巨噬细胞炎症蛋白-2(MIP-2)水平的升高。此外,ISO-1 减少了 APAP 诱导的肝损伤小鼠肝脏中髓过氧化物酶染色细胞和 TUNEL 阳性染色细胞的增加数量。ISO-1 抑制了肝组织中受体相互作用蛋白激酶(RIPK)3 和热休克蛋白 70 的上调。这些结果提供了额外的证据,表明抑制 MIF 活性可能对治疗急性 APAP 诱导的肝损伤具有临床疗效。